F
Farahnaz Sananbenesi
Researcher at University of Göttingen
Publications - 28
Citations - 6371
Farahnaz Sananbenesi is an academic researcher from University of Göttingen. The author has contributed to research in topics: Fear conditioning & Memory consolidation. The author has an hindex of 25, co-authored 27 publications receiving 5886 citations. Previous affiliations of Farahnaz Sananbenesi include Picower Institute for Learning and Memory & Massachusetts Institute of Technology.
Papers
More filters
Journal ArticleDOI
A microRNA signature that correlates with cognition and is a target against cognitive decline.
Rezaul Islam,Lalit Kaurani,Tea Berulava,Urs Heilbronner,Monika Budde,Tonatiuh Pena Centeno,Vakthang Elerdashvili,Maria‐Patapia Zafieriou,Eva Benito,Sinem M. Sertel,Maria Goldberg,Fanny Senner,Janos Kalman,Susanne Burkhardt,Anne Sophie Oepen,Mohammad Sadman Sakib,Cemil Kerimoglu,Oliver Wirths,Heike Bickeböller,Claudia Bartels,Frederic Brosseron,Katharina Buerger,Nicoleta‐Carmen Cosma,Klaus Fliessbach,Michael T. Heneka,Daniel Janowitz,Ingo Kilimann,Luca Kleinedam,Christoph Laske,Coraline D. Metzger,Matthias H. J. Munk,Robert Perneczky,Oliver Peters,Josef Priller,Boris Rauchmann,Nina Roy,Anja Schneider,Annika Spottke,Eike J. Spruth,Stefan J. Teipel,Maike Tscheuschler,Michael Wagner,Jens Wiltfang,Emrah Düzel,Frank Jessen,Silvio O. Rizzoli,Wolfram-Hubertus Zimmermann,Thomas G. Schulze,Peter Falkai,Farahnaz Sananbenesi,Andre Fischer +50 more
TL;DR: In this article, an integrative approach combining the analysis of human data and mechanistic studies in model systems was used to identify a circulating 3-microRNA signature that reflects key processes linked to neural homeostasis and inform about cognitive status.
Journal ArticleDOI
Cdk5 in the adult non-demented brain
TL;DR: The view that Cdk5 represents a good drug target in AD accompanied by cognitive dysfunctions may have to be revisited, and targeting the mechanisms up-stream of Ctk5 leading to deregulation of Ckk5 activity, such as proteolytic cleavage of its activating subunits may prove to be more beneficial as a therapeutical approach.
Posted ContentDOI
A novel miR-99b-5p-Zbp1 pathway in microglia contributes to the pathogenesis of schizophrenia
Lalit Kaurani,Md. Rezaul Islam,Urs Heilbronner,Dennis M. Krüger,Jiayin Zhou,Aditi Methi,Judith Strauss,Ranjit Pradhan,Susanne Burkhardt,Tonatiuh Pena,Lena Erlebach,Anika Bühler,Monika Budde,Fanny Senner,Mojtaba Oraki Kohshour,Eva C. Schulte,Max Schmauss,Eva Z. Reininghaus,Georg Juckel,Deborah Kronenberg-Versteeg,Ivana Delalle,Francesca Odoardi,Alexander Flügel,Thomas G. Schulze,Peter Falkai,Farahnaz Sananbenesi,Andre Fischer +26 more
TL;DR: In this article , the miR-99b-5p-Zbp1 pathway in microglia was found to contribute to the pathogenesis of schizophrenia in both the prefrontal cortex and blood of patients.